Company: NUTR
Filing Date: 2025-08-15
Form Type: 424B4
Source: 0001641172-25-024294
Chunk: 1

Company: NUSATRIP Inc
Filing Date: 2025-08-15
Form: 424B4
Chunk 1
---
 in the future, you will not have the same protections afforded to stockholders of companies that are subject to all of Nasdaq corporate governance requirements. See “Risk Factors — the Company is a “controlled company” within the meaning of the NASDAQ corporate governance standards and, as a result, will be entitled to rely on exemptions from certain corporate governance requirements that provide protections to stockholders”and “Controlled Company Exemption.”In addition, after the offering, Society Pass Incorporated controls 74.4% of the voting power of the Company’s outstanding voting securities.

|                              |     | Per Share |      |     | Total |            |
|:-----------------------------|:----|:----------|-----:|:----|:------|-----------:|
| Public offering price        |     | $         | 4.00 |     | $     | 15,000,000 |
| Underwriting                 
 discounts and commissions(1) |     | $         | 0.28 |     | $     |  1,050,000 |
| Proceeds to us,              
 before expenses(2)           |     | $         | 3.72 |     | $     | 13,950,000 |

(1) We have agreed to pay Cathay Securities, Inc., as the representative (the “Representative”) of the underwriters named in this prospectus, an underwriting discount equal to seven percent (7.0%) of the gross proceeds of the offering.

(2) The amount of offering proceeds to us presented in this table does not give effect to the exercise of the over-allotment option issued to the Underwriter.

We have agreed to issue to the Representative, on the closing date of this offering, warrants in an amount equal to seven percent (7.0%) of the aggregate number of shares of Common Stock sold by us in this offering and exercisable at a price per share equal to one hundred and twenty-five percent (125%) of the public offering price (the “Underwriter’s Warrants”). In addition, we have agreed to pay a non-accountable expense allowance to the Representative equal to 1% of the gross proceeds received at the closing of the offering. For a description of compensation to be received by the Underwriter, see “ Underwriting” for more information.

We have granted the underwriters an option, exercisable for up to 45 days from the date of this prospectus, to purchase a maximum of 562,500 shares of Common Stock (equal